Kapruvia approved by European Commission for hemodialysis patients
First approved therapy in Europe for the treatment of chronic kidney disease (CKD)-associated pruritus in hemodialysis patients
First approved therapy in Europe for the treatment of chronic kidney disease (CKD)-associated pruritus in hemodialysis patients
Landmark procedure restores 32-year-old CKD patient’s health, highlighting how public insurance is widening access to advanced renal care
New facility in Sector 51 offers advanced, affordable, and patient-centric dialysis services for NCR patients
Renalyx will continue operating as an independent unit within the group
Deceased donor kidney transplants are time-critical, and it is uncommon to attempt them robotically
Changhua site meets international regulatory standards for global medical applications
Being a premium partner for pharmaceutical companies by contributing to safety and productivity of pharmaceutical manufacture
Construction of the plant will commence in 2025 with first production expected to be in 2027
SIBUR is developing a special grade of polycarbonate compatible with radiation sterilization
Subscribe To Our Newsletter & Stay Updated